Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 902219 Boston, MA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$27,073,867
+$24,274,035 QoQ
Shares Held
3,975,605
+534.7% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 208 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority Sole 0% Shared 78% None 22%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. TSHA ranks #57 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in TSHA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,073,867 3,975,605
2026-03-31 $2,799,832 626,361
2025-12-31 $3,911,792 711,235
2025-09-30 $1,857,379 568,006
2025-06-30 $1,469,085 635,968
2025-03-31 $869,025 625,198
2024-12-31 $1,013,077 585,594
2024-09-30 $931,015 463,192
2020-09-30 $378,313 16,889